Sponsored by:

Nuclear Medicine: Page 278

Canadian court approves ART bankruptcy
By AuntMinnie.com staff writers
Optical molecular imaging developer ART Advanced Research Technologies has received approval from the Quebec Superior Court for the company's proposal to file for bankruptcy.
December 10, 2009
FDA issues final cGMP rules for PET drugs
By Wayne Forrest
The U.S. Food and Drug Administration on December 10 issued its final rule on current good manufacturing practices (cGMPs) for all PET radiopharmaceuticals, noting that the regulations may have a "significant impact on a substantial number" of small manufacturers.
December 10, 2009
NRG endorses Petten site for reactor
By AuntMinnie.com staff writers
Dutch radiopharmaceutical producer Nuclear Research and Consultancy Group (NRG) has expressed its preference for Petten, Netherlands, as the site of its proposed research reactor.
December 7, 2009
Canadian panel promotes new reactor
By AuntMinnie.com staff writers
The Canadian government should build a new nuclear reactor to produce medical isotopes and guarantee an adequate supply for the country, an expert panel has recommended.
December 7, 2009
CMS considers F-18 NaF PET coverage
By AuntMinnie.com staff writers
The U.S. Centers for Medicare and Medicaid Services (CMS) has begun taking feedback on a proposal to cover F-18 sodium fluoride (F-18 NaF) PET imaging studies to identify bone metastasis of cancer under certain conditions.
December 7, 2009
Study recommendations improve injection-to-scan time, PET quantification
By Wayne Forrest
CHICAGO - Researchers at Ohio State University Medical Center have found that injection-to-scan time in FDG-PET is "critically important" for accurately and quantitatively evaluating response to therapy, but optimum target times are complicated by patient and technology challenges.
December 2, 2009
Thinking Systems shows PACS/RIS at RSNA
By AuntMinnie.com staff writers
Thinking Systems is showcasing its upgraded PACS and RIS that have been optimized for multimodality functionality, particularly for molecular imaging.
December 1, 2009
3D software boosts diagnostic accuracy for Alzheimer's
By Wayne Forrest
CHICAGO - 3D stereotactic surface projection (3D-SSP) software enhances the diagnostic accuracy and confidence of both beginner and expert radiologists when interpreting FDG-PET scans of patients with mild cognitive impairment or Alzheimer's disease, according to a study from the Mayo Clinic in Rochester, MN.
November 30, 2009
Bayer initiates phase III trial
By AuntMinnie.com staff writers
Bayer HealthCare Pharmaceuticals has announced enrollment of the first patient in an international phase III open-label, multicenter, nonrandomized, single-dose clinical trial to evaluate the efficacy and safety of its new PET imaging agent.
November 30, 2009
F-18 fluoride PET/CT may better manage painful bone metastases
By Wayne Forrest
CHICAGO - Fluorine-18 (F-18) fluoride ion PET/CT may help predict which metastatic lesions will be painful in the thoracolumbar spine, potentially leading to better preventive treatment for those patients, according to researchers from Stanford University.
November 28, 2009
FDG-PET/CT trumps CT in detecting anal carcinoma
By Wayne Forrest
FDG-PET/CT is superior to CT for detecting primary and nodal disease in anal carcinoma and is "highly predictive" of increased progression-free survival, according to a presentation at the recent American Society for Radiation Oncology meeting in Chicago.
November 24, 2009
2009 11 24 12 44 24 337 Lien Image02 Thumb
Lawson nets funding for Tc-99m research
By AuntMinnie.com staff writers
The Lawson Health Research Institute in London, Ontario, has received more than $1 million for research into developing alternative methods for producing medical isotopes.
November 19, 2009
Previous Page
Page 278 of 440
Next Page